April 23rd 2024
OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA gene, the company stated in a news release.
Pegcetacoplan shows increasing beneficial effects after 30 months of continuous treatment for GA
August 2nd 2023Data from the 30 month GALE extension study indicated that continuous treatment with pegcetacoplan injection showed increasing beneficial effects over that timeframe in patients with geographic atrophy (GA).